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S-Adenosylmethionine serves as the methyl donor for
many biological methylation reactions and provides the
propylamine group for the synthesis of polyamines. S-
Adenosylmethionine is synthesized from methionine
and ATP by the enzyme methionine adenosyltrans-
ferase. The cellular factors regulating S-adenosylmethi-
onine synthesis have not been well defined. Here we
show that in rat hepatocytes S-nitrosoglutathione mo-
noethyl ester, a cell-permeable nitric oxide donor, mark-
edly reduces cellular S-adenosylmethionine content via
inactivation of methionine adenosyltransferase by S-ni-
trosylation. Removal of the nitric oxide donor from the
incubation medium leads to the denitrosylation and re-
activation of methionine adenosyltransferase and to the
rapid recovery of cellular S-adenosylmethionine levels.
Nitric oxide inactivates methionine adenosyltrans-
ferase via S-nitrosylation of cysteine 121. Replacement
of the acidic (aspartate 355) or basic (arginine 357 and
arginine 363) amino acids located in the vicinity of cys-
teine 121 by serine leads to a marked reduction in the
ability of nitric oxide to S-nitrosylate and inactivate
hepatic methionine adenosyltransferase. These results
indicate that protein S-nitrosylation is regulated by the
basic and acidic amino acids surrounding the target
cysteine.
In the liver S-adenosylmethionine (AdoMet)1 serves as the
methyl donor for many biological methylation reactions (such
as DNA, proteins, phospholipids, and adrenergic, dopaminer-
gic, and serotoninergic molecules) and provides the propyla-
mine group for the synthesis of polyamines (1–3). AdoMet is
synthesized from methionine and ATP by the enzyme methio-
nine adenosyltransferase (MAT). There are two MAT genes;
one is expressed only in the liver, and the other is expressed in
extrahepatic tissues and fetal liver (2–4). Up to 85% of all
methylation reactions and as much as 50% of methionine me-
tabolism occur in the liver (5), which agrees with this tissue
having the highest specific activity of MAT (6). Moreover, in the
liver the half-life of AdoMet is of only about 5 min (6).
Reduced levels of AdoMet and/or MAT activity, resulting in
the abnormal metabolism of methionine, have been found in
human cirrhosis and in a variety of experimental models in-
cluding liver injury induced by ethanol, CCl4, and galactosa-
mine (3, 7). The importance of this alteration in AdoMet syn-
thesis in the pathogenesis of a variety of liver disorders is
suggested by the finding that exogenous AdoMet administra-
tion protects from the hepatotoxic effect induced by a variety of
agents, such as ethanol, CCl4, paracetamol, tumor necrosis
factor, and galactosamine (3, 7). The cellular factors regulating
hepatic AdoMet levels are beginning to be defined. One such
factor is nitric oxide (NO). In previous studies we demonstrated
that conditions that induce NO synthesis, such as septic shock
and hypoxia, induce the inactivation of hepatic MAT without
affecting the expression of the liver-specific MAT gene (8, 9).
Further, we have reported previously that incubation of rat hepa-
tocytes with S-nitrosoglutathione monoethyl ester (EGSNO), a
cell-permeable NO donor, induces MAT inactivation (10). We
have also shown that purified rat liver MAT is inactivated by
incubation with NO donors (3-morpholinosydnonimine, S-nitro-
so-N-acetylpenicillamine, and S-nitrosoglutathione) (8, 10). In
addition, we have recently demonstrated that liver MAT is S-
nitrosylated both in vitro and in vivo (10), and further, we have
identified cysteine 121 as the site of molecular interaction of NO
and liver MAT (8). Because these results indicate that NO (or
related molecules) is a critical regulator of liver MAT activity, we
were interested in whether AdoMet content in hepatocytes is
regulated by NO.
There are few studies trying to identify the active site fea-
tures that control protein S-nitrosylation. It has been recently
proposed (11) that protein S-nitrosylation involves an acid-
base-catalyzed nitrosothiol (SNO)/SH exchange reaction,
where the target cysteine residue is localized next to basic and
acidic amino acids. Here, we were interested in determining
the structural factors that govern liver MAT S-nitrosylation
and inactivation using liver recombinant enzyme and mutants
of MAT where the acidic and basic amino acids in the vicinity
of cysteine 121 were replaced by serine by site-directed mu-
tagenesis. Recognition of the topology involved in protein S-
nitrosylation is likely to prove useful in identifying new targets
of protein S-nitrosylation.
EXPERIMENTAL PROCEDURES
Isolation and Incubation of Hepatocytes—Hepatocytes were isolated
from normally fed Wistar rats (250 g) as described previously (10).
Isolated hepatocytes were incubated in the absence or presence of
EGSNO at 37 °C. At the indicated periods of time, 2 ml of the cell
suspension (2 3 106 cells/ml) were poured into precooled centrifuge
tubes and washed twice with phosphate/saline buffer. Hepatocytes were
then used for AdoMet or MAT activity determinations. Cell viability
was determined before and after incubations by the trypan blue exclu-
sion test. Only preparations with viability over 85% were used.
AdoMet Measurements—AdoMet concentration was determined by
high pressure liquid chromatography following the procedure described
by Fell et al. (12) modified by Miller et al. (13). Samples of 2 3 106
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hepatocytes washed twice in phosphate/saline buffer were homogenized
in 200 ml of 0.4 M perchloric acid. Homogenates were centrifuged at
10,000 3 g and 4 °C for 15 min. 100 ml of the supernatant were analyzed
on a Bio-Sil® ODS-5S column equilibrated in 0.01 M ammonium for-
mate, 4 mM heptanesulfonic acid, pH 4.0. Elution was carried out with
a 31-min linear gradient of acetonitrile (0–25%) in the same buffer.
Chromatograms were analyzed using the Beckman System Gold
software.
Site-directed Mutagenesis; Purification and Characterization of MAT
Mutants—Mutants are identified by a number that indicates the resi-
due in the sequence of the enzyme that has been replaced. MAT mu-
tants C121S, D355S, D355E, R357S, R363S, R363K, G359S, and
R357S/R363S were obtained by inverse polymerase chain reaction ac-
cording to the procedure of Serrano et al. (14) using the plasmid pSSRL,
which includes a 1.2-kilobase pair fragment containing the rat liver
MAT coding region (15). The mutants were identified by sequencing of
the complete MAT cDNA. Expression and purification of WT (wild type)
and mutant proteins were carried out as described previously (15).
Protein purity was greater than 95% in all preparations as determined
by SDS-polyacrylamide gel electrophoresis. Protein concentration was
measured using the Bio-Rad protein assay kit based on the Bradford
assay (16). The recombinant WT and MAT mutants analyzed presented
similar values of specific activity: 4.36 6 0.28, 4.19 6 0.72, 3.97 6 0.91,
4.22 6 0.31, 3.89 6 0.74, 4.23 6 0.41, 4.89 6 0.52, 4.01 6 0.67, and
4.12 6 0.37 nmol/min/mg protein for WT, C121S, D355S, D355E,
R357S, R363S, R363K, G359S, and R357S/R363S, respectively. To ex-
clude that mutant proteins presented any major alteration in their
tertiary structure, fluorescence analysis was performed using a Perkin-
Elmer LS-5B fluorimeter. Emission spectra were recorded between 290
and 440 nm in 5 mM Tris, pH 7.4, with excitation wavelength set at 280
nm. Protein concentration was 0.02 mg/ml. No differences were ob-
served when the spectra of recombinant WT and MAT mutants were
compared.
Determination of MAT S-Nitrosylation—MAT S-nitrosylation was
measured according to the procedure described by Ruiz et al. (10).
Briefly, samples of purified recombinant MAT (0.4 mg/ml) were incu-
bated with S-nitrosoglutathione (GSNO) at 37 °C for 10 min. The excess
GSNO was removed by DEAE chromatography. S-Nitrosylated proteins
were incubated with 2.2 mM HgCl2, and the amount of NO released was
measured by the chemiluminescence derived from its reaction with
ozone using a Sievers NOA 280 nitric oxide analyzer. Standard curves
were obtained with known concentrations of GSNO.
MAT Activity Measurements—MAT activity was measured as de-
scribed by Cabrero et al. (17) using saturating concentrations of the
substrates, 5 mM methionine and 5 mM ATP, in the absence of any
reducing agent. Samples of 2 3 106 hepatocytes, prepared as mentioned
above, were washed twice in phosphate/saline buffer and homogenized
by freezing and thawing in 10 mM Tris/HCl, 0.3 M sucrose, and 1 mM
EGTA, pH 7.5, containing 0.1% phenylmethylsulfonyl fluoride and 0.1%
benzamidine. Cytosol was obtained by centrifugation at 100,000 3 g at
4 °C. Excess EGSNO was removed by DEAE chromatography on a 1-ml
column (10), and the enzyme activity was measured. Samples of puri-
fied WT and mutant recombinant rat liver MAT were incubated for 10
min at 37 °C in the presence or absence of GSNO or peroxynitrite. After
incubation, excess GSNO or peroxynitrite was removed by DEAE chro-
matography (10), and the enzyme activity was measured.
Preparation of GSNO, EGSNO, and Peroxynitrite—GSNO and
EGSNO were prepared according to Ruiz et al. (10). Briefly, equimolar
concentrations of an aqueous solution of NaNO2 and a freshly prepared
GSH or EGSH solution in 250 mM HCl and 0.1 M EDTA, pH 1.5, were
mixed. The resulting mixture was incubated at room temperature for 5
min and then neutralized with NaOH. Peroxynitrite synthesis was
carried out by the method described by Beckman et al. (18) modified by
Pannala et al. (19). Only freshly prepared solutions of GSNO, EGSNO,
and peroxynitrite were used.
Cytosolic Nitrite and Nitrate Measurements—Cytosolic nitrite and
nitrate (NOx) were reduced to NO by incubation with 1 N HCl contain-
ing 50 mM VCl3 (10). The resulting NO was measured by the chemilu-
minescence derived from its reaction with ozone using a Sievers NOA
280 nitric oxide analyzer (10).
RESULTS
NO Reduces AdoMet Content in Hepatocytes—The effect of
NO on the content of AdoMet was examined in isolated rat
hepatocytes. Incubation of rat hepatocytes with the cell-perme-
able NO donor EGSNO (5 mM) induced a time-dependent re-
duction of the cellular AdoMet content (Fig. 1). Within 15 min
of the addition of EGSNO to the incubation medium, the hep-
atocyte content of AdoMet decreased about 80%, i.e. from
1.03 6 0.08 nmol of AdoMet/106 cells in control hepatocytes to
0.22 6 0.035 nmol of AdoMet/106 cells in hepatocytes treated
with the NO donor (Fig. 1). The reversibility of the depletion of
AdoMet by EGSNO in isolated rat hepatocytes was examined
by removing the NO donor from the incubation medium and
resuspending the cells in fresh buffer without EGSNO (Fig. 1).
Within 15 min of the removal of the NO donor and resuspen-
sion of the cells in fresh medium without EGSNO, cellular
AdoMet content returned close to that of untreated hepatocytes
(Fig. 1). When hepatocytes were maintained in the presence of
the NO donor, the depletion of the cellular content of AdoMet
was maintained during the next 15 min (Fig. 1). As previously
demonstrated (10), incubation with EGSNO within 15 min
induced the inactivation of MAT (from 36.4 6 0.5 pmol/min/mg
of protein in control hepatocytes to 10.95 6 2.8 pmol/min/mg of
protein in the presence of 5 mM EGSNO). Removal of the NO
donor from the incubation medium returned MAT activity to
values similar to those of the untreated hepatocytes (29.18 6
1.1 pmol/min/mg of protein) within 15 min.
We next analyzed whether the effect of EGSNO on AdoMet
content in hepatocytes was dose-dependent (Fig. 2). The addi-
tion of EGSNO (0.5–5 mM) to isolated rat hepatocytes induced
a dose-dependent accumulation of NOx, which led to a progres-
sive depletion of AdoMet content (Fig. 2). Significant reduction
of the AdoMet content in hepatocytes was already observed at
1 mM EGSNO, a condition where intracellular NOx increased
about 5-fold. The addition of EGSNO to isolated rat hepato-
cytes induced, as described previously (10), a dose-dependent
inactivation of MAT activity (data not shown).
The Structural Factors That Govern Liver MAT S-Nitrosyla-
tion—S-Nitrosylation of recombinant WT rat liver enzyme and
mutants of MAT was measured after reaction with various
concentrations of GSNO (5–100 mM). In WT rat liver, MAT
incubation for 10 min with 100 mM GSNO produced the S-
nitrosylation of about 1.3 thiol residues/enzyme subunit (Fig.
3). Incubation with GSNO also induced the inactivation of the
enzyme. As shown in Fig. 4, there is a close inverse correlation
between the extent of S-nitrosylation and loss of activity in-
duced by GSNO (r 5 0.95, p , 0.001). Incorporation of 1 mol of
SNO/mol of MAT subunit led to about 80% inactivation of MAT.
Maximal S-nitrosylation and inactivation were obtained within
10 min of incubation with GSNO (data not shown). We have
previously shown (8) that replacement of cysteine 121 by serine
(referred to as C121S) prevented the ability of NO donors to
FIG. 1. Effect of EGSNO on AdoMet content in isolated rat
hepatocytes. Isolated rat hepatocytes were incubated in the absence
(l) or in the presence (f) of 5 mM EGSNO. After incubation with
EGSNO for 55 min, The NO donor was removed from the medium by
centrifugation, and after washing the cells twice, the hepatocytes were
resuspended in the absence (E) or presence (f) of 5 mM EGSNO.
AdoMet content was determined as described under “Experimental
Procedures” at the times indicated in the figure. Values are expressed
as means 6 S.E. of three independent experiments in duplicate.
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inactivate hepatic MAT. Consistently, incubation of C121S
with GSNO (5–100 mM) resulted in the incorporation of only
about 0.2 mol of (SNO) per mol of MAT subunit. The mecha-
nism of protein S-nitrosylation has been recently proposed (11)
to involve an acid-base-catalyzed SNO/SH exchange reaction,
where the target cysteine residue is located next to basic and
acid amino acids. In human and rat liver MAT, cysteine 121 is
not flanked by acid and basic amino acids but by glutamine and
valine (20–22). However, when the three-dimensional struc-
ture of liver MAT is analyzed, one residue of aspartic acid
(Asp-355) and two residues of arginine (Arg-357, Arg-363) are
all found in the vicinity of the sulfur group of cysteine 121 (Fig.
5). Replacement of aspartic acid 355 by serine (D355S) mark-
edly reduced the S-nitrosylation of the mutant enzyme in the
presence of GSNO (Fig. 3). Replacement of arginine 357
(R357S) or of arginine 363 (R363S) by serine led also to a
marked reduction of the S-nitrosylation of the mutant enzyme
as compared with the WT liver MAT (Fig. 3). Further, a double
mutant, where arginine 357 and arginine 363 were both re-
placed by serine (R357S/R363S) incorporated only about 0.4
mol of SNO/mol of MAT subunit after incubation with 100 mM
GSNO (Fig. 3). As negative controls, we have replaced arginine
363 by lysine (R363K) and aspartic acid 355 by glutamic acid
(D355E) and observed that these conservative changes had no
effect on the S-nitrosylation of the mutant enzymes by GSNO
as compared with the WT liver MAT. Fig. 3 shows the results
obtained with the mutant enzyme R363K; similar results were
observed with the mutant enzyme D355E (data not shown). As
an additional control we have changed glycine 359, a non-
charged residue that is separated by 5.3 Å from the thiol group
of cysteine 121, to serine (G359S) and observed that this mu-
tation had no effect on the S-nitrosylation of the mutant en-
zyme by GSNO (data not shown). These controls provide evi-
dence that the effects on MAT S-nitrosylation of changing
arginine 357, arginine 363, or aspartic acid 355 to serine are
due to loss of charge and not to alterations in the position of
cysteine 121. Finally, similarly to the WT recombinant MAT,
incubation of mutants D355S, D355E, R357S, R363S, R363K,
G359S, and R357S/R363S with millimolar concentrations of
GSNO resulted in the incorporation of about 10 mol of SNO/mol
of MAT subunit, indicating that all cysteine residues present in
the protein (21) were S-nitrosylated.
We next analyzed whether these mutants showing impaired
MAT S-nitrosylation were resistant to GSNO-induced enzyme
inactivation. Whereas incubation of the WT recombinant en-
zyme with 50 mM GSNO led to 70% reduction of the enzyme
activity, replacement of cysteine 121 by a serine residue pre-
vented the ability of GSNO to inactivate liver MAT (Fig. 6).
Replacement of aspartic acid 355, arginine 357, or arginine 363
by serine led to a marked reduction of the ability of GSNO to
inactivate liver MAT (Fig. 6). Further, replacement of both
FIG. 2. Effect of EGSNO on AdoMet content and NOx levels.
Hepatocytes were incubated with various concentrations of EGSNO.
Cytosolic AdoMet (l) and NOx (E) content were determined after 20
min of incubation with the NO donor as described under “Experimental
Procedures.” Values are expressed as means 6 S.E. of three independ-
ent experiments in duplicate.
FIG. 3. Dose-dependent S-nitrosylation of WT and mutant rat
liver MAT by GSNO. Recombinant MAT purified from Escherichia
coli transformed with WT and mutant cDNA were incubated in the
presence of various concentrations of GSNO for 10 min. The formation
of SNO groups was determined as described under “Experimental Pro-
cedures.” Values are expressed as means 6 S.E. of three experiments in
triplicate using different preparations of the enzyme. E, WT; l, C121S;
f, R363S/R357S; , R357S; , R363S; M, D355S; , R363K. Mutants
are identified by a number that indicates the amino acid residue in the
sequence of the enzyme that has been replaced.
FIG. 4. Correlation between extent of MAT S-nitrosylation and
loss of activity. MAT purified from E. coli transformed with WT
mutant cDNA was incubated in the presence of various concentrations
of GSNO (5–100 mM) for 10 min at 37 °C. The enzyme activity and the
formation of SNO groups were then determined as described under
“Experimental Procedures.” MAT activity is expressed as the percent of
activity remaining after treatment with GSNO. Values are the mean 6
S.E. of three different enzyme preparations (r 5 0.95; p , 0.001).
FIG. 5. A model structure of rat liver MAT. The structural detail
of the microenvironment of cysteine 121 is based on a model structure
for the rat liver MAT subunit published previously (32) using the data
available for the x-ray crystal structure of E. coli MAT (33, 34). This
figure was prepared with Ras Mol (35). The position of cysteine 121
(C121), arginine 357 (R357), arginine 363 (R363), and aspartic acid 355
(D355) are indicated. According to this model, the distances between
the SH group of cysteine 121 and the guanidino groups of arginine 357
and arginine 363 are 3.3 and 4.4 Å, respectively. The distance between
the SH group of cysteine 121 and the g-COOH of aspartic acid 355 is 4.9
Å.
Methionine Adenosyltransferase S-Nitrosylation 17077









arginine 357 and arginine 363 by serine was as effective as the
substitution of cysteine 121 by serine to prevent GSNO-in-
duced MAT inactivation (Fig. 6). On the contrary, replacement
of arginine 363 by lysine, aspartic acid 355 by glutamic acid, or
glycine 359 by serine did not affect the ability of GSNO to
inactivate liver MAT. Fig. 6 shows the results obtained with
the mutant enzyme R363K; similar results were observed with
the mutant enzymes D355E and G359S (data not shown).
Incubation of WT liver MAT for 10 min with 50 mM peroxyni-
trite also induced the inactivation of the enzyme (Fig. 7). As
expected, incubation of WT liver MAT with peroxynitrite did
not result in the S-nitrosylation of the enzyme (data not
shown). Whereas replacement of cysteine 121 by serine pre-
vented the ability of peroxynitrite to inactivate liver MAT,
replacement of aspartic acid 355 or arginine 363 by serine, or
replacement of both arginine 357 and arginine 363 by serine
had no effect on the inactivation of the enzyme by peroxynitrite
(Fig. 7). These results indicate that whereas arginine 357,
arginine 363, and aspartic acid 355 are needed for transnitro-
sation of cysteine 121, these residues are unneeded for the
interaction of this thiol with peroxynitrite. Moreover, these
results provide further evidence that in these mutants cysteine
121 is not buried in the protein.
DISCUSSION
Our results indicate that NO or related molecules can regu-
late AdoMet content in hepatocytes via reversible NO-medi-
ated S-nitrosylation and inactivation of hepatic MAT. An in-
crease in the hepatic levels of NO induces a rapid
S-nitrosylation and inactivation of hepatic MAT (10), which
leads to a rapid depletion of the AdoMet content. Conversely,
the elimination of the NO source leads to the rapid denitrosy-
lation and activation of hepatic MAT (10) and to the rapid
increase of the AdoMet content. This agrees with the observa-
tion that the half-life of hepatic AdoMet is only about 5 min (6).
Further, our results indicate that a moderate increase in the
hepatocyte levels of NO, as observed during incubation with 1
mM EGSNO, is sufficient to have a significant effect on AdoMet
content. We have previously established (9) that in rat hepa-
tocytes kept under low oxygen levels MAT is inactivated. Fur-
ther we also found that in rat hepatocytes hypoxia induced the
expression of NO synthase and that the inactivation of MAT
during hypoxia was prevented by the NO synthase inhibitor
NG-monomethyl-L-arginine methyl ester (9). Elevated levels of
NO or related molecules may contribute to the abnormal me-
tabolism of methionine in patients with liver cirrhosis. Hyper-
methioninemia, reduced hepatic MAT activity, and decreased
content of liver AdoMet have been detected in patients with
liver cirrhosis and/or in experimental models of chronic liver
injury (23–28). In patients with liver cirrhosis and in experi-
mental models of chronic liver disorders serum levels of NOx
are elevated (29, 30). The serum NOx levels in patients with
liver cirrhosis have been reported to increase up to 10-fold
(from 3 mM in control subjects to 34 mM in cirrhosis) (30).
Although it is not known what may be the concentration of NOx
in the cirrhotic liver, the present results indicate that 50 mM
GSNO inactivate liver MAT by about 60%. These data are
evidence for a pathophysiological interruption of AdoMet me-
tabolism by NO.
NO inhibits many enzymes by S-nitrosylation of active site
and regulatory thiols (31). It is not yet known, however, what
structural factors govern the modification of a specific protein
cysteine residue by NO. An acid-base-catalyzed SNO/SH ex-
change reaction, where the target cysteine residue is located
next to basic and acid amino acids, has been recently proposed
FIG. 8. A model for the reaction of cysteine 121 with GSNO.
Whereas the guanidino moiety of arginines 357 and 363 facilitates the
deprotonation of the sulfur group of cysteine 121 and thus increases its
nucleophilicity, the g-COOH group of aspartic acid 355 facilitates the
protonation of GSNO and consequently enhances the donation of its NO
group.
FIG. 6. Inactivation of WT and mutant rat liver MAT by GSNO.
MAT purified from E. coli transformed with WT and mutant cDNA were
incubated in the absence or presence of 50 mM GSNO for 10 min. The
enzyme activity was then measured as described under “Experimental
Procedures.” Results are expressed as the percent of activity remaining
after treatment with GSNO for each individual mutant. Values are
expressed as mean 6 S.E. of three different preparations. Mutants are
identified by a number that indicates the amino acid residue in the
sequence of the enzyme that has been replaced.
FIG. 7. Inactivation of WT and mutant rat liver MAT by per-
oxynitrite. MAT purified from E. coli transformed with WT and mu-
tant cDNA were incubated in the absence or presence of 50 mM per-
oxynitrite for 10 min. The enzyme activity was then measured as
described under “Experimental Procedures.” Results are expressed as
the percent of activity remaining after treatment with peroxynitrite for
each individual mutant. Values are expressed as mean 6 S.E. of three
different preparations. Mutants are identified by a number that indi-
cates the amino acid residue in the sequence of the enzyme that has
been replaced.
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(11). The NO-mediated inactivation of hepatic MAT appears to
occur through S-nitrosylation of the residue of cysteine 121 of
the enzyme (8, 10). Our results indicate that the substitution of
cysteine 121 by serine prevents MAT S-nitrosylation and inac-
tivation by GSNO. Further we show that there is a close in-
verse correlation between the extent of S-nitrosylation and loss
of activity. Cysteine 121 is localized at a “flexible loop” over the
active site cleft of MAT (32–34). This loop can adopt two dif-
ferent conformations, open and closed, and it has been pro-
posed that in the closed conformation prevents the entrance of
the substrates to the active site (34). Cysteine 121 is not essen-
tial for activity because the substitution of this amino acid
residue by serine has no effect on MAT activity (15). The
present results suggest that formation of a SNO group in cys-
teine 121 induces a conformational change in the “flexible loop”
making less accessible the active site of the enzyme for the
substrates, probably by switching the loop into the closed con-
formation. Replacement of the acidic amino acid (Asp-355) or of
any of the two basic amino acids (Arg-357, Arg-363) localized in
the proximity of cysteine 121 by serine markedly reduced the
capacity of GSNO to S-nitrosylate and inactivate liver MAT.
Further, our results indicate that GSNO-induced MAT S-ni-
trosylation and inactivation are greatly prevented in a double
mutant enzyme where arginine 357 and arginine 363 were both
replaced by serine. When the changes did not involve loss of
charge (arginine 363 by lysine and aspartic acid 355 by glu-
tamic acid) these mutations had no effect on the S-nitrosylation
and inactivation of the mutant enzymes by GSNO. Our results
also indicate that the change of a non-charged amino acid
(glycine 359) in the vicinity of cysteine 121 by serine did not
affect S-nitrosylation and inactivation of the mutant enzyme by
GSNO. We also show that peroxynitrite-induced MAT inacti-
vation involves the reaction of this oxidizing agent with cys-
teine 121. In this case, however, replacement of arginine 357,
arginine 363, or aspartic acid 355 by serine did not affect
peroxynitrite-induced MAT inactivation. These results indicate
that the decreased GSNO-mediated MAT S-nitrosylation and
inactivation seen following replacement of acidic and basic
residues in the vicinity of cysteine 121 with serine are because
of loss of charge and are not because of structural changes that
alter the position or otherwise protect the thiol. One possible
explanation of these findings is that the function of the gua-
nidino groups of arginine 357 and arginine 363 may be to
facilitate the deprotonation of the sulfur group of cysteine 121
(Fig. 8). This will increase the nucleophilicity of cysteine 121
(by lowering its pKa) and consequently facilitate the nitrosyla-
tion of its sulfur group. The function of the g-COOH group of
aspartic acid 355 may be to facilitate the protonation of GSNO
and, accordingly, facilitate the donation of its NO group. These
results provide the first experimental evidence that, as pro-
posed by Stamler et al. (11), the S-nitrosylation of protein thiol
residues is governed by the basic and acidic amino acids sur-
rounding the target thiol. Recognition of this topology is likely
to prove useful in identifying new targets of protein
S-nitrosylation.
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